Baseline characteristics
Characteristic . | N = 53 . |
---|---|
Age | |
Median, y (range) | 59 (35-81) |
≥ 65 y, n (%) | 23 (43) |
Sex | |
Male, n (%) | 39 (74) |
Female | 14 (26) |
ISS stage, n (%) | |
I | 21 (40) |
II | 18 (34) |
III | 14 (26) |
Durie-Salmon stage, n (%) | |
I | 7 (13) |
II | 12 (24) |
III | 34 (63) |
Unfavorable cytogenetics, n (%)* | 17/51 (33) |
del 13†/hypodiploidy | 10/50 (20) |
t(4;14) | 5/49 (10) |
t(14;16) | 0/48 (0) |
del 17p | 7/48 (15) |
Characteristic . | N = 53 . |
---|---|
Age | |
Median, y (range) | 59 (35-81) |
≥ 65 y, n (%) | 23 (43) |
Sex | |
Male, n (%) | 39 (74) |
Female | 14 (26) |
ISS stage, n (%) | |
I | 21 (40) |
II | 18 (34) |
III | 14 (26) |
Durie-Salmon stage, n (%) | |
I | 7 (13) |
II | 12 (24) |
III | 34 (63) |
Unfavorable cytogenetics, n (%)* | 17/51 (33) |
del 13†/hypodiploidy | 10/50 (20) |
t(4;14) | 5/49 (10) |
t(14;16) | 0/48 (0) |
del 17p | 7/48 (15) |